A

AM-Pharma

47 employees

AM-Pharma is a biopharmaceutical company focused on the development of therapeutics to treat inflammatory and infectious diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Clinical study
recAP
Biotech
Biopharma
Medical
Health Care
Sepsis
AKI

Date founded

2002

Funding rounds raised

Total raised

$130M

from 23 investors over 23 rounds

A

AM-Pharma raised undisclosed on July 1, 2021

Investors: Eurazeo

A

AM-Pharma raised $26M on March 31, 2020

Investors: European Investment Bank

A

AM-Pharma raised $25M on March 31, 2020

Investors: Forbion, Ysios Capital, Idinvest Partners, Andera Partners and Gilde Healthcare

A

AM-Pharma raised undisclosed on March 1, 2020

Investors: Eurazeo

A

AM-Pharma raised $130M on July 16, 2019

Investors: Pureos Bioventures, EQT Life Sciences, Gilde Healthcare, Forbion, Ysios Capital, Andera Partners and Idinvest Partners

A

AM-Pharma raised $16M on September 11, 2014

Investors: Gilde Healthcare, Inventages Venture Capital and Ysios Capital

A

AM-Pharma raised $40M on September 13, 2011

Investors: Ysios Capital and Idinvest Partners

A

AM-Pharma raised undisclosed on August 11, 2011

Investors: Idinvest Partners

A

AM-Pharma raised $3.4M on August 7, 2007

Investors: Forbion

A

AM-Pharma raised undisclosed on February 26, 2002

Investors: ABN AMRO Energy Transition Fund

FAQ